INSTITUT-BIOTHERAPIES
Company in France
Resume
Myotubular Myopathy : Genethon welcomes interim data of a phase I / II clinical trial with a gene therapy product developed in its laboratories > Institut Des Biothérapies
last updated on October 17th, 2024